Skip to main content

Envisioning is an emerging technology research institute and advisory.

LinkedInInstagramGitHub

2011 — 2026

research
  • Reports
  • Newsletter
  • Methodology
  • Origins
  • My Collection
services
  • Research Sessions
  • Signals Workspace
  • Bespoke Projects
  • Use Cases
  • Signal Scanfree
  • Readinessfree
impact
  • ANBIMAFuture of Brazilian Capital Markets
  • IEEECharting the Energy Transition
  • Horizon 2045Future of Human and Planetary Security
  • WKOTechnology Scanning for Austria
audiences
  • Innovation
  • Strategy
  • Consultants
  • Foresight
  • Associations
  • Governments
resources
  • Pricing
  • Partners
  • How We Work
  • Data Visualization
  • Multi-Model Method
  • FAQ
  • Security & Privacy
about
  • Manifesto
  • Community
  • Events
  • Support
  • Contact
  • Login
ResearchServicesPricingPartnersAbout
ResearchServicesPricingPartnersAbout
Injectable Delivery Innovations | Aura | Envisioning
  1. Home
  2. Research
  3. Aura
  4. Injectable Delivery Innovations

Injectable Delivery Innovations

Needle-free jet microinjectors and programmable implants.
BACK TO AURA

Related Organizations

Langer Lab (MIT)

US · Research Lab

95%

Robert Langer's lab at MIT, famous for pioneering drug delivery systems, including programmable implants and microneedles.

Researcher
Portal Instruments

US · Startup

95%

Developing a needle-free, high-pressure jet injection device based on MIT research.

Developer
NanoPass

IL · Company

90%

Developed MicronJet, a MEMS-based hollow microneedle device for intradermal delivery.

Developer

Prausnitz Lab (Georgia Tech)

US · Research Lab

90%

Mark Prausnitz's lab focuses on microneedle patches for transdermal drug delivery.

Supporting Evidence

Evidence data is not available for this technology yet.

Connections

Explore this signal in your context

Get a focused view of implications, timing, and action options for your organization.
Discuss this signal
VIEW INTERACTIVE VERSION
Researcher
AbbVie (Allergan Aesthetics)

US · Company

85%

Parent company of Botox and Juvederm.

Investor
Corium

US · Company

85%

A commercial-stage biopharmaceutical company focused on transdermal delivery systems.

Developer
Cosmed Pharmaceutical

JP · Company

85%

Japanese pharmaceutical company that pioneered the development of hyaluronic acid microneedles for cosmetic use (Quanis brand).

Developer
Galderma

CH · Company

85%

A major pharmaceutical company specializing in dermatology and injectables (Restylane, Dysport).

Deployer
SoftFil

FR · Company

80%

Specializes in micro-cannulas for aesthetic injections, reducing pain and bruising compared to needles.

Developer
Applications
Applications
Peptide-Based Injectables

Botox alternatives targeting neuromuscular junctions with peptides.

TRL
8/9
Impact
5/5
Investment
5/5
Hardware
Hardware
Bioactive Wearables

Patches delivering micro-doses via transdermal channels.

TRL
8/9
Impact
5/5
Investment
5/5
Hardware
Hardware
Robotic Dermal Procedure Platforms

Robotic microneedling and laser systems for precision work.

TRL
7/9
Impact
5/5
Investment
5/5
Hardware
Hardware
Microneedling Devices

Motorized dermal pens and stamps delivering collagen induction therapy.

TRL
8/9
Impact
5/5
Investment
4/5
Hardware
Hardware
Closed-Loop Dermal Wearables

Sensor–actuator patches adjusting output in real time.

TRL
5/9
Impact
5/5
Investment
4/5
Applications
Applications
Transdermal Beauty Patches

Slow-release patches delivering actives overnight.

TRL
6/9
Impact
4/5
Investment
4/5

Injectable delivery innovations span high-pressure jet injectors, piezoelectric microneedle arrays, and programmable sub-dermal reservoirs that release actives over weeks. Multi-chamber cartridges keep peptides, hyaluronic acids, and neuromodulators isolated until the moment of delivery, while onboard thermal control and ultrasound guidance maintain viscosity and placement inside delicate facial planes.

For high-volume med-spas and concierge clinics, these systems reduce chair time, bruising, and practitioner fatigue while enabling novel protocols such as micro-dosed contouring or body-wide peptide stacks. Galderma, Revelle Aesthetics, and a wave of Korean OEM consoles are piloting injectors that pair digital twins of the face with RFID-tagged formulations, creating an audit trail that satisfies both regulators and discerning clients.

The category still requires rigorous clinical validation to avoid over-reliance on automation, so savvy operators combine AI dosing suggestions with human override workflows. Expect hybrid service models where patients leave with companion wearable reservoirs that top up injectables between visits, turning delivery hardware into an ongoing subscription funnel rather than a one-off device sale.

TRL
5/9Validated
Impact
5/5
Investment
4/5
Category
Hardware

Newsletter

Follow us for weekly foresight in your inbox.

Browse the latest from Artificial Insights, our opinionated weekly briefing exploring the transition toward AGI.
Mar 8, 2026 · Issue 131
Mar 8, 2026 · Issue 131
Prompt it into existence
Feb 23, 2026 · Issue 130
Feb 23, 2026 · Issue 130
An Apocaloptimist
Feb 9, 2026 · Issue 129
Feb 9, 2026 · Issue 129
Agent in the Loop
View all issues